Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Spectra Optia Apheresis Red Blood Cell Exchange Protocol in Patients With Sickle Cell Disease.

NCT01736657 is registered in ClinicalTrials.gov with Terumo BCT as lead sponsor.

NCT NCT01736657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01736657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Spectra Optia Apheresis Red Blood Cell Exchange Protocol in Patients With Sickle Cell Disease.
Lead sponsor
Terumo BCT
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
June 30, 2013
Enrollment
73 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease